Search

everythinglearnresearchcommunity

for

Search:↓

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Tofacitinib helped regrow hair in a woman with alopecia areata.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

DPR can cause skin, hair, and nail issues, sometimes appearing later in life.

Efficient enzyme function relies on specific residue interactions and structural coordination.

A mutation in the vitamin D receptor causes severe resistance to vitamin D, affecting bone health but not hair growth.

Blood pressure medications may increase the risk of skin cancer.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Temporal triangular alopecia usually starts in early childhood and treatment with Minoxidil has limited effectiveness.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A specific gene mutation causes vitamin D-resistant rickets and hair loss.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

SVF-PRP therapy effectively reverses hair loss effects.

After moderate COVID-19, cardiovascular patients had fewer respiratory issues but faced new physical and psychological problems.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Venlafaxine can cause urinary incontinence in rare cases.

Extracellular vesicles help heal skin wounds and could be used for better treatments.